Eric Dy, PhD (’14)

Eric is co-founder and CEO of Bloomlife, a digital health company designing the future of prenatal care.

Eric brings a unique perspective on the needs, opportunities, and challenges in emerging healthcare technologies and delivery models informed by multi-disciplinary technical expertise and insight gained through business development in consumer and medical markets.

Prior to co-founding Bloomlife, Eric served as senior business development manager at IMEC leading sales and partnership activities in North America. In his 3 years leading sales activities in North America, Eric generated $25M+ in revenue from partnerships covering next gen sequencing, remote patient monitoring, hyperspectral imaging, and mixed-signal chip design.

Eric earned his BSc in Bioengineering from Cornell and his MSc and Ph.D. in Biomedical Engineering from UCLA. He is (co)-author of 14 scientific publication and 9 patents.

Eric says he owes a great deal of gratitude for his time at UCLA as a graduate student. Through his work in the lab and the opportunities outside of the lab, he gained not only deep technical expertise but many of the skills required to start a company. According to Eric, a Ph.D. requires a highly tuned ability to take complex problems and break them down into small pieces and prioritize de-risking the biggest risks first. It also requires the confidence to step into the unknown and figure things out that no one has before. Both are similar to what you face in starting a company.

"Beyond that the network that came with an investment from the UCLA VC Fund helped to catalyze significant funding from major investors," he told the VC Fund. "My hope is to give back what UCLA and the UCLA VC Fund has given me."

To learn more about how Bloomlife is designing the future of prenatal care, visit their website at!